 - Peripheral blood progenitor cell graft transplantation: Patients receive T-cell depleted, peripheral blood progenitor cells PBPC by IV infusion on day 0. Beginning 1 day after completion of the PBPC infusion, patients receive filgrastim G-CSF subcutaneously once daily until blood counts recover. 